Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Sida Pharmaceutical is a comprehensive pharmaceutical enterprise based in Haikou, Hainan Province, China, focused on the development and manufacturing of generic drugs. The company's product portfolio is heavily weighted toward anti-infectives, particularly cephalosporin antibiotics, as well as treatments for digestive and cardiovascular systems. Operating from a large-scale, GMP-certified production base, Hainan Sida produces multiple dosage forms including lyophilized powder injections and solid oral preparations. The firm is a significant player in the regional pharmaceutical industry and maintains a strong distribution network across China. Its strategic focus remains on the consistency evaluation of its core generic products to maintain competitiveness in the centralized procurement market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 海南斯达制药.